$PODD

AI 分析

生成于 May 11, 2026

AI Score
72/ 100
Hold$PODD

Insulet Corporation

$PODDNASDAQHealthcareLarge-Cap

Insulet develops the Omnipod insulin management system, a tubeless insulin pump for diabetes management.

Market Cap
$18.0B
Revenue (TTM)
$2.2B
+18.0%
Net Income (TTM)
$0.2B
+25.0%
EPS (TTM)
$2.80
P/E Ratio
72.0
Dividend Yield
0.0%
52-Week Range
$155-$275
Beta
0.82
Dimension Scores
Fundamental
66
Technical
68
Sentiment
76
Risk / Reward
64
Momentum
78
FundTechSentRiskMome
Financial Health
Profitability
71moderate
Growth
81strong
Liquidity
72strong
Solvency
68strong
Efficiency
64strong

Valuation, technical analysis, investment thesis, risk assessment and more for $PODD

Free · No credit card required

免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。

探索更多

用 AI 分析任意股票

获取涵盖基本面、技术面、情绪面、风险评估和投资论点的结构化研究报告——约 60 秒完成。